Case File
efta-02579494DOJ Data Set 11OtherEFTA02579494
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02579494
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Jeffrey Epstein <[email protected]>
Sent:
Friday, January 24, 2014 3:34 PM
To:
Vahe Stepanian
Subject:
Re: CAD Trade Premium [C]
standing instructions or a balance kept there whatever =asier
On Fri, Jan 24, 2014 at 10:56 AM, Vahe Stepanian «= href="mailto
target=' blank"
wrote:
Classification: Co=fidential
Jeffrey,
Following up conversations with both Harry and Darren (CC'ed).
Attached is a letter of authorization (LOA) for your signature to wire USD to DB London to cover the premium on
last week's CAD trade.
The reason for the LOA:
For FX (and many other OTC trades), DB AG London will be your counterpar=y. So, when there is premium paid,
that money needs to go from your DB NY account to DB AG London.
(a) We can set up standing instructions:
A standing LOA from your DB NY account to DB London can be set up. We can make these instructions require
your (or Harry/Jeanne's) verbal con=irmation before any money moves (this can be done upon trade). This will avoid an
LOA needing to be signed for every trade. You (or Harry) will still need to sign OTC confirms (standard).
Or
(b) You (or Harry/Jeanne) can sign an LOA for each relevant trade
Please let us know which you prefer.
Thank you,
Vahe
Vahe Stepanian
Associate I Wealth Investment Coverage
Deutsche Bank Securities Inc.
Deutsche Asset & Wealth Management
345 Park Avenue - 26th Floor
EFTA_R1_01754260
EFTA02579494
New York, NY 10154.0004
Tel.
<tel
Fax
<tel:
Mobile
Email
This communication may contain confidential and/=r privileged information.
If you are not the intended recipient (or have received this communication<=r> in error) please notify the sender
immediately and destroy this
communication. Any unauthorized copying, disclosure or distribution of the<=r> material in this communication
is strictly forbidden.
Deutsche Bank does not render legal or tax advice, and the information
contained in this communication should not be regarded as such.
The information contained in this commun=cation is
confidential, may be attorney-client privileged, may
constitute inside i=formation, and is intended only for
the use of the addressee. It is the=property of
Jeffrey Epstein
Unauthorized use, disclosure or copying=of this
communication or any part thereof is strictly prohibited
and may be unla=ful. If you have received this
communication in error, please notify us=immediately by
return e-mail or by e-mail to [email protected] <mailto:[email protected]> , and
destroy this communication and all copies thereof,
including all attachm=nts. copyright -all rights reserved
2
EFTA_R1_01754261
EFTA02579495
Technical Artifacts (4)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.